TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients

NCT00133887 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

77

Enrollment

OTHER

Sponsor class

Conditions

Skin Cancer
Kidney Transplantation

Interventions

DRUG: rapamycin
DRUG: ciclosporine
DRUG: tacrolimus

Sponsor

Hospices Civils de Lyon